CoChat

Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential

Open access
Pak, Linda M., Kemeny, Nancy E., Capanu, Marinela, Chou, Joanne F., Boucher, Taryn, Cercek, Andrea, Balachandran, Vinod P., Kingham, T. Peter, Allen, Peter J., DeMatteo, Ronald P., Jarnagin, William R., D'Angelica, Michael I. · 2018 · Journal of Surgical Oncology
Cited by 119

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background/Objectives: Combination hepatic artery infusion (HAI) and systemic (SYS) chemotherapy for unresectable CRLM results in high tumor‐response rates. This study represents an update of long‐term survival and conversion to resectability in patients with unresectable CRLM treated with HAI and SYS chemotherapy in a phase II study. Method: The primary endpoint was complete resection. Multivariate and landmark analysis assessed the effect of complete resection on progression‐free (PFS) and overall survival (OS). Results: From 2007 to 2012, 64 patients with median of 13 tumors were enrolled; 67% had prior chemotherapy. 33 patients (52%) were converted to resection. Median follow‐up among survivors was 81 months. Median PFS and OS were 13 and 38 months, respectively, with 5‐year‐OS of 36%. Chemotherapy‐naïve patients had 5‐year‐OS of 51%. Conversion to resection was the only independent factor prognostic of improved PFS and OS. Nine of 64 patients (14%) are NED (five since initial resection, three after resection of recurrent disease, one from chemotherapy alone) at median follow‐up of 86 months from treatment initiation, and 72 months from last operative intervention. Conclusion: Combination HAI and SYS is an effective therapy for high‐volume unresectable CRLM, resulting in a high rate of resection, long‐term survival, and the potential for cure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jso.24898

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 119

Metadata

Authors
Pak, L. M., Kemeny, N. E., Capanu, M., Chou, J. F., Boucher, T., Cercek, A., Balachandran, V. P., Kingham, T. P., Allen, P. J., DeMatteo, R. P., Jarnagin, W. R., & D'Angelica, M. I.
Venue
Journal of Surgical Oncology
Publisher
Wiley
Published
2017-11-22
Volume
117
Issue
4
Pages
634-643
ISSN
  • 0022-4790 (ISSN-L)
  • 1096-9098
OpenAlex
W2768830411
Cited by
119
References
6
FWCI
2.80
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.